Digital pediatric-behavioral-health company Cognoa announced today the appointment of David Happel as its new CEO. He comes from biopharmaceutical company Chrono Therapeutics, which he led as president, CEO and director, as well as stints at Horizon Therapeutics, Raptom Pharma, Allergen Research Corporation and others.
Brent Vaughan, Cognoa's cofounder and former CEO, will be serving in an...